
SSNC Stock Forecast & Price Target
SSNC Analyst Ratings
Bulls say
SS&C Technologies Holdings demonstrated a positive revenue trajectory, with a 7% year-over-year growth on an organic constant currency basis, reflecting an acceleration from the previous quarters. The company's fourth-quarter revenue reached $1.53 billion, marking an 8.4% increase year-over-year, bolstered by strong performances in intelligent automation and analytics, as well as a resurgence in their healthcare segment. Additionally, the company’s strategic acquisitions, including Intralinks and Blue Prism, are anticipated to yield synergies that enhance revenue and EPS growth moving forward.
Bears say
SS&C Technologies Holdings faces a negative outlook primarily due to rising interest rates, high inflation, and geopolitical tensions, which could lead to a prolonged economic downturn impacting revenue and earnings per share (EPS) in the asset management industry. The company's financial health is further complicated by a reliance on debt financing for acquisitions, which may hinder growth if credit markets tighten, while limited revenue transparency restricts investor insight into business performance and risks. Additionally, the recent adjustments in healthcare-related license deals highlight the volatility in revenue streams, which, compounded with a lack of clarity in key performance metrics, raises concerns regarding future financial stability.
This aggregate rating is based on analysts' research of SS&C Technologies Hlds and is not a guaranteed prediction by Public.com or investment advice.
SSNC Analyst Forecast & Price Prediction
Start investing in SSNC
Order type
Buy in
Order amount
Est. shares
0 shares